131 related articles for article (PubMed ID: 32807268)
1. Preparation of PrP-specific Polyclonal Antibody
Yang XH; Wu YZ; Xiao K; Gao LP; Chen DD; Dong XP; Shi Q
Biomed Environ Sci; 2020 Jul; 33(7):493-501. PubMed ID: 32807268
[TBL] [Abstract][Full Text] [Related]
2. Preparation of monoclonal antibodies against prion proteins with full-length hamster PrP.
Xiao XL; Jiang HY; Zhang J; Han J; Nie K; Zhou XB; Huang YX; Chen L; Zhou W; Zhang BY; Liu Y; Dong XP
Biomed Environ Sci; 2005 Aug; 18(4):273-80. PubMed ID: 16274110
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils.
Spinner DS; Kascsak RB; Lafauci G; Meeker HC; Ye X; Flory MJ; Kim JI; Schuller-Levis GB; Levis WR; Wisniewski T; Carp RI; Kascsak RJ
J Leukoc Biol; 2007 Jun; 81(6):1374-85. PubMed ID: 17379700
[TBL] [Abstract][Full Text] [Related]
4. Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform.
Wong BS; Li R; Sassoon J; Kang SC; Liu T; Pan T; Greenspan NS; Wisniewski T; Brown DR; Sy MS
Cell Mol Life Sci; 2003 Jun; 60(6):1224-34. PubMed ID: 12861388
[TBL] [Abstract][Full Text] [Related]
5. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
6. Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP(0/0) mice.
Nakamura N; Miyamoto K; Shimokawa M; Nishida N; Mohri S; Kitamoto T; Horiuchi H; Furusawa S; Matsuda H
Hybrid Hybridomics; 2003 Aug; 22(4):263-6. PubMed ID: 14511572
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a prion disease PrP(Sc) panel from the brain tissues of experimental hamsters infected with scrapie agent 263K].
Zhang BY; Tian C; Han J; Gao C; Shi Q; Jiang HY; Zhou W; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):321-3. PubMed ID: 19469162
[TBL] [Abstract][Full Text] [Related]
8. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
9. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
[TBL] [Abstract][Full Text] [Related]
10. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
11. Generation of antisera to purified prions in lipid rafts.
Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
Prion; 2010; 4(2):94-104. PubMed ID: 20647769
[TBL] [Abstract][Full Text] [Related]
12. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
13. Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
Chen C; Xu XF; Zhang RQ; Ma Y; Lv Y; Li JL; Shi Q; Xiao K; Sun J; Yang XD; Shi Q; Dong XP
Prion; 2017 Sep; 11(5):338-351. PubMed ID: 28956708
[TBL] [Abstract][Full Text] [Related]
14. Anti-PrP antibodies detected at terminal stage of prion-affected mouse.
Sassa Y; Kataoka N; Inoshima Y; Ishiguro N
Cell Immunol; 2010; 263(2):212-8. PubMed ID: 20417929
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
16. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
17. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
18. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
19. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ
J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405
[TBL] [Abstract][Full Text] [Related]
20. Applicability of three anti-PrP peptide sera including staining of tonsils and brainstem of sheep with scrapie.
Garssen GJ; Van Keulen LJ; Farquhar CF; Smits MA; Jacobs JG; Bossers A; Meloen RH; Langeveld JP
Microsc Res Tech; 2000 Jul; 50(1):32-9. PubMed ID: 10871546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
